CGCT vs MS

Morgan Stanley (MS) offers the better valuation at 21.

0x trailing P/E (18. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Morgan Stanley (MS) is the cheapest at 21.

0x versus Cartesian Growth Corporation III at 61. 4x.

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +154.

7%, compared to +53. 1% for Cartesian Growth Corporation III (CGCT). Over 10 years, the gap is even starker: MS returned +854. 4% versus CGCT's +53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cartesian Growth Corporation III (CGCT) is the lower-risk stock at 0.

25β versus Morgan Stanley's 1. 40β — meaning MS is approximately 464% more volatile than CGCT relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Cartesian Growth Corporation III grew EPS 589.

2% year-over-year, compared to 28. 3% for Morgan Stanley. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Morgan Stanley (MS) is the more profitable company, earning 14.

7% net margin versus 0. 0% for Cartesian Growth Corporation III — meaning it keeps 14. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 19. 1% versus 0. 0% for CGCT. At the gross margin level — before operating expenses — MS leads at 57. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, MS (1.

9% yield) pays a dividend. CGCT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.

9% yield, +854. 4% 10Y return). Both have compounded well over 10 years (MS: +854. 4%, CGCT: +53. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

MS pays a dividend while CGCT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.